Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 595
Gene Symbol: CCND1
CCND1
0.010 AlteredExpression disease BEFREE The expression of Ki67, cyclin D1, c-Met, IMP3, and β-catenin showed a significant difference between OSF and NOM samples. 27497264 2017
Entrez Id: 6347
Gene Symbol: CCL2
CCL2
0.010 AlteredExpression disease BEFREE Similarly, differences in the CCL2-CT expression were statistically significant between control vs. OSMF (P = 0.00086), control vs. early OSMF (P = 0.02914), and control vs. advanced OSMF (P = 0.0006). 28029690 2017
Entrez Id: 28
Gene Symbol: ABO
ABO
0.010 Biomarker disease BEFREE The chi-square analysis could not establish any significant relationship between OSMF and ABO blood group. 27072224 2016
Entrez Id: 135112
Gene Symbol: NCOA7
NCOA7
0.010 Biomarker disease BEFREE The present study suggests that NCOA7 is a potential biomarker for early diagnosis of OSF malignant transformation, and leads to a better understanding of the molecular mechanisms responsible for OSCC development. 27509054 2016
Entrez Id: 4792
Gene Symbol: NFKBIA
NFKBIA
0.010 GeneticVariation disease BEFREE Chromosomal DNA isolated from twenty five each of OSMF and OL tissue biopsy samples were subjected to PCR amplification with intronic primers flanking twenty four exons of the NFKB gene. 27510021 2016
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
0.010 Biomarker disease BEFREE Out of the 349 genes, 34 (including several S100 gene family members) were found to be deleted and 30 (containing NOTCH4, TP53 and ERBB2) were found as amplified in OSF and OC cases. 24969693 2015
Entrez Id: 4855
Gene Symbol: NOTCH4
NOTCH4
0.010 Biomarker disease BEFREE Out of the 349 genes, 34 (including several S100 gene family members) were found to be deleted and 30 (containing NOTCH4, TP53 and ERBB2) were found as amplified in OSF and OC cases. 24969693 2015
Entrez Id: 6285
Gene Symbol: S100B
S100B
0.010 Biomarker disease BEFREE Out of the 349 genes, 34 (including several S100 gene family members) were found to be deleted and 30 (containing NOTCH4, TP53 and ERBB2) were found as amplified in OSF and OC cases. 24969693 2015
Entrez Id: 4193
Gene Symbol: MDM2
MDM2
0.010 Biomarker disease BEFREE Expressions of COX-2, p53, and MDM2 increased with OSF progression. 26369479 2015
Entrez Id: 841
Gene Symbol: CASP8
CASP8
0.010 GeneticVariation disease BEFREE The identification of mutations in OSCC lesions but not OSMF suggests that dimer forming domain mutations in caspase 8 may be limited to malignant lesions. 26107208 2015
Entrez Id: 2261
Gene Symbol: FGFR3
FGFR3
0.010 Biomarker disease BEFREE The present study was undertaken to analyze expression of FGF-2 and its receptors FGFR-2 and FGFR-3 in 72 PMOLs, 108 OSCC and 52 healthy controls, and their role in risk assessment for malignant transformation of Leukoplakia (LKP) and Oral submucous fibrosis (OSMF) to OSCC. 26465941 2015
Entrez Id: 4071
Gene Symbol: TM4SF1
TM4SF1
0.010 Biomarker disease BEFREE miR-203 inhibits arecoline-induced epithelial-mesenchymal transition by regulating secreted frizzled-related protein 4 and transmembrane-4 L six family member 1 in oral submucous fibrosis. 25872484 2015
Entrez Id: 2263
Gene Symbol: FGFR2
FGFR2
0.010 Biomarker disease BEFREE The present study was undertaken to analyze expression of FGF-2 and its receptors FGFR-2 and FGFR-3 in 72 PMOLs, 108 OSCC and 52 healthy controls, and their role in risk assessment for malignant transformation of Leukoplakia (LKP) and Oral submucous fibrosis (OSMF) to OSCC. 26465941 2015
Entrez Id: 3342
Gene Symbol: HTC2
HTC2
0.010 Biomarker disease BEFREE Using array-CGH, the present study aimed to explore genome-wide profiles of chromosomal aberrations in samples of oral cancer (OC), oral submucous fibrosis (OSF) and their corresponding normal oral mucosa from Indian (n=18) and OC from Sri Lankan (n=12) patients with history of BQ use, and correlate the findings to other clinicopathological parameters. 24969693 2015
Entrez Id: 406986
Gene Symbol: MIR203A
MIR203A
0.010 Biomarker disease BEFREE Thus, we provide evidence to illustrate that miR-203 plays a role in the pathogenesis of OSF, which may be a target for OSF management. 25872484 2015
Entrez Id: 574501
Gene Symbol: MIR499A
MIR499A
0.010 GeneticVariation disease BEFREE The T/C+C/C genotypes of MiR-499a may contribute to an increased risk of BQ-related OSF, but a decreased risk of OSCC. miR-499a T>C influences the expression levels of miR-499a-5p during the tumorigenesis of OSCC. 24690080 2015
Entrez Id: 6424
Gene Symbol: SFRP4
SFRP4
0.010 Biomarker disease BEFREE miR-203 inhibits arecoline-induced epithelial-mesenchymal transition by regulating secreted frizzled-related protein 4 and transmembrane-4 L six family member 1 in oral submucous fibrosis. 25872484 2015
Entrez Id: 11197
Gene Symbol: WIF1
WIF1
0.010 PosttranslationalModification disease BEFREE Furthermore, WIF1 was frequently methylated in OSCC cases with betel quid chewing habit, but not in normal oral mucous and different stages of OSF tissues, suggesting WIF1 methylation is tumor-specific in the development of OSF. 26352791 2015
Entrez Id: 6271
Gene Symbol: S100A1
S100A1
0.010 Biomarker disease BEFREE Out of the 349 genes, 34 (including several S100 gene family members) were found to be deleted and 30 (containing NOTCH4, TP53 and ERBB2) were found as amplified in OSF and OC cases. 24969693 2015
Entrez Id: 23430
Gene Symbol: TPSD1
TPSD1
0.010 AlteredExpression disease BEFREE Altered immunohistochemical expression of mast cell tryptase and chymase in the pathogenesis of oral submucous fibrosis and malignant transformation of the overlying epithelium. 24874976 2014
Entrez Id: 768
Gene Symbol: CA9
CA9
0.010 AlteredExpression disease BEFREE Increased expression of carbonic anhydrase IX in oral submucous fibrosis and oral squamous cell carcinoma. 24695043 2014
Entrez Id: 6275
Gene Symbol: S100A4
S100A4
0.010 AlteredExpression disease BEFREE Initially, S100A4 expression was higher in areca quid chewing-associated OSF specimens than normal buccal mucosa specimens (p = 0.001). 23383075 2013
Entrez Id: 6046
Gene Symbol: BRD2
BRD2
0.010 GeneticVariation disease BEFREE Heterozygous XRCC3 codon 241 [OR 2.07 (1.05-4.06)], homozygous variant of NAT C481T [OR 2.81 (1.09-7.21)], and both heterozygous and homozygous variants of NAT codon 268 and 286 [OR 2.31 (1.20-4.45) and 4.98 (1.87-13.14), and 6.12 (2.75-13.62) and 2.65 (1.04-6.72)] individually influenced susceptibility to OSF in the population. 22092501 2012
Entrez Id: 10
Gene Symbol: NAT2
NAT2
0.010 GeneticVariation disease BEFREE Gene-gene interaction analysis by multifactor dimensionality reduction (MDR) revealed that XRCC3 Thr 241 Met had the largest univariate effect followed by XRCC3 Thr 241 Met - NAT2 A857G in men that presents a highly synergistic interaction as one of the potential combinations of single nucleotide polymorphisms (SNPs) to increase the risk of OSF in men if exposed to arecanut or smokeless tobacco usage. 22092501 2012
Entrez Id: 4087
Gene Symbol: SMAD2
SMAD2
0.010 Biomarker disease BEFREE Areca nut water extract treatment induced p-SMAD2 and TGF-β downstream targets in HaCaT cells but not in human gingival fibroblast cells (hGF), suggesting epithelial cells could be the source of TGF-β in promoting OSF. 23284772 2012